InSure技术治疗极早产儿呼吸窘迫综合征失败的高危因素分析

李婷; 姜红; 刘冬云; 李向红

doi:10.7499/j.issn.1008-8830.2014.06.010

PDF(1191 KB)

HTML

中国当代儿科杂志 ›› 2014, Vol. 16 ›› Issue (6) : 610-613. DOI: 10.7499/j.issn.1008-8830.2014.06.010

论著·临床研究

InSure技术治疗极早产儿呼吸窘迫综合征失败的高危因素分析

李婷, 姜红, 刘冬云, 李向红

作者信息 +

Risk factors for the failure of the InSure method in very preterm infants with respiratory distress syndrome

LI Ting, JIANG Hong, LIU Dong-Yun, LI Xiang-Hong

Author information +

Department of Neonatology, The Affiliated Hospital of Qingdao University, Qingdao, Shandong 266003, China

Aboat authors:

[1] Sweet D, Bevilacqua G, Carnielli V, et al. European consensus guidelines on the management of neonatal respiratory distress syndrome[J].Perinat Med, 2007, 35(1): 175-186.
[2] Sweet D, Bevilacqua G, Carnielli V, et al. 欧洲新生儿呼吸窘迫综合征防治指南-2010 版[J].中华儿科杂志, 2011, 49(1): 27-33.
[3] 金汉珍, 黄德氓, 官希吉. 实用新生儿学[M]. 第3 版. 北京: 人民卫生出版社, 2003: 421-428.
[4] 邵肖梅, 叶鸿帽, 丘小汕. 实用新生儿学[M]. 第4 版. 北京: 人民卫生出版社, 2010: 395-398.
[5] Dani C, Bertini G, Pezzati M, et al. Early extubation and nasal continuous positive airway pressure after surfactant treatment for respiratory distress syndrome among preterm infants <30 weeks' gestation[J].Pediatrics, 2004, 113(6): e560-e563.
[6] Stevens TP, Harrington EW, Blennow M, et al. Early surfactant administration with brief ventilation vs. selective surfactant andcontinued mechanical ventilation for preterm infants with or at risk for respiratory distress syndrome[J/OL]. Cochrane Database Syst Rev, 2007(4): CD003063.
[7] Andersen T, Holm HS, Kamper J. Surfactant treatment of newborn infants receiving continuous positive airway pressure treatment[J].Ugeskr Laeger, 2006, 23(168): 3723-3727.
[8] Reininger A, Khalak R, Kendig JW, et al. Surfactant administration by transient intubation in infants 29 to 35 weeks' gestation with respiratory distress syndrome decreases the likelihood of later mechanical ventilation: a randomized controlled trial[J].Perinatol, 2005, 25(11): 703-708.
[9] David G. Sweet, Virgilio Carnielli, Gorm Greisen, et al. European consensus guidelines on the management of neonatal respiratory distress syndrome in preterm infants-2013 Update[J].Neonatology, 2013, 103(4): 353-368.
[10] Dani C, Corsini I, Bertini G, et al. The INSURE method in preterm infants of less than 30 weeks'gestation[J].Matern Fetal Neonatal Med, 2010, 23(9): 1024-1029.
[11] Cherif A, Hachani C, Khrouf N. Risk factors of the failure of surfactant treatment by transient intubation during nasal continuous positive airway pressure in preterm infants[J].Am J Perinatol, 2008, 25(10): 647-652.
[12] Jobe AH, Mitchell RR, Gunkel JH. Beneficial effects of the combined use of prenatal corticosteroids and postnatal surfactant on preterm infants[J].Am J Obstet Gynecol 1993, 168(2): 508-513.

Show less

文章历史 +

摘要

目的分析InSure 技术治疗极早产儿呼吸窘迫综合征（RDS）失败的高危因素。方法回顾分析应用InSure 技术治疗的71 例RDS 极早产儿的临床资料，其中治疗成功组42 例，失败组29 例，比较两组患儿的一般情况，并行多因素logistic 回归分析。结果 InSure 技术失败率为41%。失败组在出生体重、产前糖皮质激素使用率、经阴道分娩率明显低于成功组（P<0.05），而动脉导管未闭发生率较成功组显著增加（P<0.05）；失败组的PaO₂、PaO₂/FiO₂、PaO₂/PAO₂ 均明显低于成功组（P<0.05），且PaCO₂ 较成功组明显增高（P<0.05）。Logistic 回归分析显示出生体重<1150 g（OR=22.240、95%CI=2.124~232.901）、PaCO₂>54 mm Hg（OR=9.360、95%CI=1.958~44.741）、及PaO₂/FiO₂<195（OR=6.570、95%CI=1.027~42.003）是InSure 技术治疗RDS 失败的独立危险因素。此外，失败组氧疗时间、住院时间及BPD 发生率均明显高于成功组（P<0.05）。结论 InSure技术治疗极早产儿RDS 失败的高危因素包括低出生体重、高PaCO₂ 及低PaO₂/FiO₂。

Abstract

Objective To study the risk factors for the failure of the InSure method in very preterm infants with respiratory distress syndrome (RDS). Methods Seventy-one very preterm infants with RDS treated with InSure method were enrolled. These infants were categorized into two groups: InSure success (42 cases) and InSure failure (29 cases). The differences in basic information were compared between the two groups, and logistic regression analysis was used to identify the risk factors for InSure failure. Results The failure rate of the InSure method was 41%. The failure group were much lower in the birth weight, the antenatal steroids utilization rate and the vaginal delivery rate than the success group (P<0.05). The incidence of patent ductus arteriosus in the failure group was significantly higher than in the success group (P<0.05). PaO₂, PaO₂/FiO₂ and PaO₂/PAO₂ in the failure group were significantly lower than in the success group (P<0.05). PaCO₂ in the failure group was much higher than in the success group (P<0.05). Further logistic regression analysis showed that birth weight <1 150 g (OR=22.240 95%CI=2.124-232.901), PaCO₂>54 mm Hg(OR=9.360, 95%CI=1.958-44.741, and PaO₂/FiO₂ <195 (OR=6.570, 95%CI=1.027-42.003), were the independmend risk factors for InSure failure. Furthermore, the duration of oxygen therapy, the total time of hospitalization and the incidence of BPD in the failure group were much longer and higher than in the success group (P<0.05). Conclusions Low birth weight, elevated PaCO₂ and low PaO₂/PiO2 ratio are the risk factors for the failure of the InSure method in very preterm infants.

导出引用

李婷, 姜红, 刘冬云, 李向红. InSure技术治疗极早产儿呼吸窘迫综合征失败的高危因素分析[J]. 中国当代儿科杂志. 2014, 16(6): 610-613 https://doi.org/10.7499/j.issn.1008-8830.2014.06.010

LI Ting, JIANG Hong, LIU Dong-Yun, LI Xiang-Hong. Risk factors for the failure of the InSure method in very preterm infants with respiratory distress syndrome[J]. Chinese Journal of Contemporary Pediatrics. 2014, 16(6): 610-613 https://doi.org/10.7499/j.issn.1008-8830.2014.06.010